1811 - 1820 of 7915 Results
Title
Year
- Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiative2022OPENTitle: Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 37Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/gps.5727Best OA location URL: https://psyarxiv.com/rxqev/downloadCitation Count: 3
- Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes2022OPENTitle: Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetesJournal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: 8Start Page: 875End Page: 882Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pds.5448Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542001Citation Count: 12
- Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing2022OPENTitle: Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editingJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 62Issue #:Start Page: 102806End Page: 102806Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2022.102806Best OA location URL: https://doi.org/10.1016/j.scr.2022.102806Citation Count: 11
- Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s disease2022RESTRICTEDTitle: Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4745End Page: 4752Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06110-yCitation Count: 6
- Vocal changes in a zebra finch model of Parkinson’s disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathway2022OPENTitle: Vocal changes in a zebra finch model of Parkinson’s disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathwayJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 5Start Page: e0265604End Page: e0265604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0265604Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0265604&type=printableCitation Count: 8
- Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes2022OPENTitle: Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromesJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-00983-zBest OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-022-00983-zCitation Count: 13
- Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms2022OPENTitle: Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN ProteoformsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 5Start Page: 1449End Page: 1462Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223285Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223285?id=journal-of-parkinsons-disease%2Fjpd223285Citation Count: 8
- Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directions2022RESTRICTEDTitle: Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directionsJournal Name: Expert Opinion on Drug SafetyPublisher: Informa UK LimitedVol: 21Issue #: 7Start Page: 873End Page: 879Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14740338.2022.2069240Best OA location URL: https://doi.org/10.1080/14740338.2022.2069240Citation Count: 8
-
RESTRICTEDTitle: Incidence of Parkinson Disease in North America (P1-1.Virtual)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.2665Citation Count: 1
- Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)2022RESTRICTEDTitle: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529Citation Count: 2